ESC Premium Access

Prescription of guideline recommended oral anticoagulation and reasons reported for non-use of OAC in patients with atrial fibrillation: Data from the German AFNET-2 Registry

Congress Presentation

About the speaker

Professor Michael Naebauer

Ludwig-Maximilians University, Munich (Germany)
0 follower

9 more presentations in this session

Autoantiboides to muscarinic m2 cholinoceptors in patients with paroxysmal atrial fibrillation

Speaker: Doctor E. Mironova (Moscow, RU)

Thumbnail

Quantitative global proteomics and lysine acetylome analysis of changes in left atrial appendage tissue from valvular heart disease patients with atrial fibrillation

Speaker: Doctor T. Tu (Changsha, CN)

Thumbnail

Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics and function through the PGC-1 signaling pathway

Speaker: Professor G. Tse (Canterbury, GB)

Thumbnail

CD8+CD28null T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery

Speaker: Doctor N. Kazem (Vienna, AT)

Thumbnail

Asymmetric and symmetric dimethylarginine in atrial fibrillation progression and recurrence

Speaker: Doctor P. Buettner (Leipzig, DE)

Thumbnail

Access the full session

Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

Speakers: Professor M. Naebauer, Doctor E. Mironova, Doctor T. Tu, Professor G. Tse, Doctor N. Kazem...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk